Literature DB >> 21664729

Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.

Anna Drabczyńska1, Olga Yuzlenko, Meryem Köse, Minka Paskaleva, Anke C Schiedel, Janina Karolak-Wojciechowska, Jadwiga Handzlik, Tadeusz Karcz, Kamil Kuder, Christa E Müller, Katarzyna Kieć-Kononowicz.   

Abstract

Syntheses and physicochemical properties of N-cycloalkyl-substituted imidazo-, pyrimido- and 1,3-diazepino[2,1-f]purinediones are described. These derivatives were synthesized by cyclization of 7-halogenoalkyl-8-bromo-1,3-dimethylxanthine derivatives with aminocycloalkanes. The obtained compounds (1-33) were evaluated for their affinity to rat adenosine A(1) and A(2A) receptors. Selected compounds were additionally investigated for affinity to the human A(1), A(2A), A(2B) and A(3) receptor subtypes. The results of the radioligand binding assays at adenosine A(1) and A(2A) receptors showed that most of the compounds exhibited adenosine A(2A) receptor affinity at micromolar or submicromolar concentrations; an annelated pyrimidine ring was beneficial for A(2A) affinity. The most potent A(2A) ligands of the present series were compounds 6 (K(i) 0.33 μM rat A(2A), 0.31 μM human A(2A)), 8 (K(i) 0.98 μM rat A(2A), 0.42 μM human A(2A)) and 15 (K(i) 0.24 μM rat A(2A), 0.61 μM human A(2A)) with the latter one showing high A(2A) selectivity. In NaCl shift assay, 15 was shown to be an antagonist at A(2A) receptors. This result was confirmed for the best compounds 6, 8, 15 in cAMP accumulation studies. A 3D-QSAR equation with a good predicting power (q(2) = 0.88) for A(2A) AR affinity was obtained. The compounds were evaluated in vivo as anticonvulsants in MES and ScMet tests and examined for neurotoxicity in mice (i.p.). Most of them showed anticonvulsant activity in chemically induced seizures; among them the diazepinopurinediones were the best (e.g. 31) showing protection in both tests on short time symptoms, without signs of neurotoxicity. Five compounds, 8, 17, 20, 29, and 31, exhibited anticonvulsant activity after peroral application in rats. Structure-activity relationships are discussed including the analysis of lipophilic and spatial properties. The new compounds, which contain a basic nitrogen atom and can therefore be protonated, may be good starting points for obtaining A(2A) antagonists with good water-solubility.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664729     DOI: 10.1016/j.ejmech.2011.05.023

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum.

Authors:  Mahmoud Fahmi Elsebai; Viktor Rempel; Gregor Schnakenburg; Stefan Kehraus; Christa E Müller; Gabriele M König
Journal:  ACS Med Chem Lett       Date:  2011-09-17       Impact factor: 4.345

2.  Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.

Authors:  Anna Drabczyńska; Tadeusz Karcz; Ewa Szymańska; Meryem Köse; Christa E Müller; Minka Paskaleva; Janina Karolak-Wojciechowska; Jadwiga Handzlik; Olga Yuzlenko; Katarzyna Kieć-Kononowicz
Journal:  Purinergic Signal       Date:  2013-04-02       Impact factor: 3.765

3.  Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases.

Authors:  Leen Kalash; Cristina Val; Jhonny Azuaje; María I Loza; Fredrik Svensson; Azedine Zoufir; Lewis Mervin; Graham Ladds; José Brea; Robert Glen; Eddy Sotelo; Andreas Bender
Journal:  J Cheminform       Date:  2017-12-30       Impact factor: 5.514

4.  KD-64-A new selective A2A adenosine receptor antagonist has anti-inflammatory activity but contrary to the non-selective antagonist-Caffeine does not reduce diet-induced obesity in mice.

Authors:  Magdalena Kotańska; Anna Dziubina; Małgorzata Szafarz; Kamil Mika; Karolina Reguła; Marek Bednarski; Małgorzata Zygmunt; Anna Drabczyńska; Jacek Sapa; Katarzyna Kieć-Kononowicz
Journal:  PLoS One       Date:  2020-06-18       Impact factor: 3.240

5.  Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties.

Authors:  Michał Załuski; Katarzyna Stanuch; Tadeusz Karcz; Sonja Hinz; Gniewomir Latacz; Ewa Szymańska; Jakub Schabikowski; Agata Doroż-Płonka; Jadwiga Handzlik; Anna Drabczyńska; Christa E Müller; Katarzyna Kieć-Kononowicz
Journal:  Medchemcomm       Date:  2018-05-14       Impact factor: 3.597

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.